Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: March 2015

Chapter 15 - Sinonasal and nasopharyngeal pathology

References

1. Mills SE, Gaffey MJ, Frierson HF. Anatomy, Histology and Embryology. In: Tumors of The Upper Aerodigestive Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 2000: pp. 1–14.
2. Pantanowitz L, Balogh K. Mouth, nose, and paranasal sinuses. In Mills SE, ed. Histology for Pathologists, 4th edn. Philadelphia, PA: Wolters Kluwer Lippincott Williams and Wilkins; 2012: pp. 433–460.
3. Stelow EB, Mills SE. Normal anatomy and histology. In Mills SE, ed. Histology for Pathologists, 4th edn. Philadelphia, PA: Wolters Kluwer Lippincott Williams and Wilkins; 2012: pp. 1–17.
4. Mills SE. Larynx and pharynx. In Mills SE, ed. Histology for Pathologists, 4th edn. Philadelphia, PA: Wolters Kluwer Lippincott Williams and Wilkins; 2012, pp. 461–477.
5. Penner CR, Thompson L. Nasal glial heterotopia: a clinicopathologic and immunophenotypic analysis of 10 cases with a review of the literature. Ann Diagn Pathol 2003; 7: 354–359.
6. Theaker JM, Fletcher CD. Heterotopic glial nodules: a light microscopic and immunohistochemical study. Histopathology 1991: 18: 255–260.
7. Heffner DK, Thompson LD, Schall DG, Anderson V. Pharyngeal dermoids (“hairy polyps”) as accessory auricles. Ann Otol Rhinol Laryngol 1996; 105: 819–824.
8. Carlen B, Stenram U. Primary ciliary dyskinesia: a review. Ultrastruct Pathol 2005; 29: 217–220.
9. Leigh MW, Pittman JE, Carson JL, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med 2009; 11: 473–487.
10. Stierna P, Carlsoo B. Histopathological observations in chronic maxillary sinusitis. Acta Otolaryngol 1990; 110: 450–458.
11. deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997; 337: 254–259.
12. Brandwein M. Histopathology of sinonasal fungal disease. Otolaryngol Clin North Am 1993; 26: 949–981.
13. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72: 89–93.
14. Waxman JE, Spector JG, Sale SR, Katzenstein AL. Allergic Aspergillus sinusitis: concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987; 97: 261–266.
15. Torres C, Ro JY, el-Naggar AK, et al. Allergic fungal sinusitis: a clinicopathologic study of 16 cases. Hum Pathol 1996; 27: 793–799.
16. Friedman GC, Hartwick RW, Ro JY, et al. Allergic fungal sinusitis. Report of three cases associated with dematiaceous fungi. Am J Clin Pathol 1991; 96: 368–372.
17. Corey JP, Romberger CF, Shaw GY. Fungal diseases of the sinuses. Otolaryngol Head Neck Surg 1990; 103: 1012–1015.
18. McGill TJ, Simpson G, Healy GB. Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope 1980; 90: 748–754.
19. Morgan MA, Wilson WR, Neel HB, 3rd, Roberts GD. Fungal sinusitis in healthy and immunocompromised individuals. Am J Clin Pathol 1984; 82: 597–601.
20. Drakos PE, Nagler A, Or R, et al. Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transpl 1993; 12: 203–208.
21. Montone KT, LiVolsi VA, Lanza DC, et al. In situ hybridization for specific fungal organisms in acute invasive fungal rhinosinusitis. Am J Clin Pathol 2011; 135: 190–199.
22. Waldman SR, Levine HL, Sebek BA, Parker W, Tucker HM. Nasal tuberculosis: a forgotten entity. Laryngoscope 1981; 91: 11–16.
23. Waldron J, Van Hasselt CA, Skinner DW, Arnold M. Tuberculosis of the nasopharynx: clinicopathological features. Clin Otolaryngol Allied Sci 1992; 17: 57–59.
24. McDougall AC, Rees RJ, Weddell AG, Kanan MW. The histopathology of lepromatous leprosy in the nose. J Pathol 1975; 115: 215–226.
25. Pollack JD, Pincus RL, Lucente FE. Leprosy of the head and neck. Otolaryngol Head Neck Surg 1987; 97: 93–96.
26. Berger SA, Pollock AA, Richmond AS. Isolation of Klebsiella ozaenae and Klebsiella rhinoscleromatis in a general hospital. Am J Clin Pathol 1977; 67: 499–502.
27. Meyer PR, Shum TK, Becker TS, Taylor CR. Scleroma (rhinoscleroma). A histologic immunohistochemical study with bacteriologic correlates. Arch Pathol Lab Med 1983; 107: 377–383.
28. Batsakis JG, el-Naggar AK. Rhinoscleroma and rhinosporidiosis. Ann Otol Rhinol Laryngol 1992; 101: 879–882.
29. Andraca R, Edson RS, Kern EB. Rhinoscleroma: a growing concern in the United States? Mayo Clinic experience. Mayo Clin Proc 1993; 68: 1151–1157.
30. Jimenez JF, Young DE, Hough AJ, Jr. Rhinosporidiosis. A report of two cases from Arkansas. Am J Clin Pathol 1984; 82: 611–615.
31. Daneshbod Y, Oryan A, Davarmanesh M, et al. Clinical, histopathologic, and cytologic diagnosis of mucosal leishmaniasis and literature review. Arch Pathol Lab Med 2011; 135: 478–482.
32. Amato VS, Tuon FF, Imamura R, et al. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil. J Eur Acad Dermatol Venereol 2009; 23: 1026–1034.
33. McDonald TJ, DeRemee RA, Kern EB, Harrison EG, Jr. Nasal manifestations of Wegener’s granulomatosis. Laryngoscope 1974; 84: 2101–2112.
34. Devaney KO, Travis WD, Hoffman G, et al. Interpretation of head and neck biopsies in Wegener’s granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990; 14: 555–564.
35. Del Buono EA, Flint A. Diagnostic usefulness of nasal biopsy in Wegener’s granulomatosis. Hum Pathol 1991; 22: 107–110.
36. Colby TV, Tazelaar HD, Specks U, DeRemee RA. Nasal biopsy in Wegener’s granulomatosis. Hum Pathol 1991; 22: 101–104.
37. Matsubara O, Yoshimura N, Doi Y, Tamura A, Mark EJ. Nasal biopsy in the early diagnosis of Wegener’s (pathergic) granulomatosis. Significance of palisading granuloma and leukocytoclastic vasculitis. Virchows Arch 1996; 428: 13–19.
38. Chumbley LC, Harrison EG, Jr., DeRemee RA. Allergic granulomatosis and angiitis (Churg–Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977; 52: 477–484.
39. Olsen KD, Neel HB, 3rd, Deremee RA, Weiland LH. Nasal manifestations of allergic granulomatosis and angiitis (Churg–Strauss syndrome). Otolaryngol Head Neck Surg 1980; 88: 85–89.
40. McCaffrey TV, McDonald TJ. Sarcoidosis of the nose and paranasal sinuses. Laryngoscope 1983; 93: 1281–1284.
41. Postma D, Fry TL, Malenbaum BT. The nose, minor salivary glands, and sarcoidosis. Arch Otolaryngol 1984; 110: 28–30.
42. Roberts PF, McCann BG. Eosinophilic angiocentric fibrosis of the upper respiratory tract: a mucosal variant of granuloma faciale? A report of three cases. Histopathology 1985; 9: 1217–1225.
43. Altemani AM, Pilch BZ, Sakano E, Altemani JM. Eosinophilic angiocentric fibrosis of the nasal cavity. Mod Pathol 1997; 10: 391–393.
44. Thompson LD, Heffner DK. Sinonasal tract eosinophilic angiocentric fibrosis. A report of three cases. Am J Clin Pathol 2001; 115: 243–248.
45. Jain R, Robblee JV, O’Sullivan-Mejia E, et al. Sinonasal eosinophilic angiocentric fibrosis: a report of four cases and review of literature. Head Neck Pathol 2008; 2: 309–315.
46. Deshpande V, Khosroshahi A, Nielsen GP, Hamilos DL, Stone JH. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol 2011; 35: 701–706.
47. Moteki H, Yasuo M, Hamano H, Uehara T, Usami S. IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol 2011; 131: 518–526.
48. Wolff M. Granulomas in nasal mucous membranes following local steroid injections. Am J Clin Pathol 1974; 62: 775–782.
49. McClatchie S, Warambo MW, Bremner AD. Myospherulosis: a previously unreported disease? Am J Clin Pathol 1969; 51: 699–704.
50. Kyriakos M. Myospherulosis of the paranasal sinuses, nose and middle ear. A possible iatrogenic disease. Am J Clin Pathol 1977; 67: 118–130.
51. Rosai J. The nature of myospherulosis of the upper respiratory tract. Am J Clin Pathol 1978; 69: 475–481.
52. Sercarz JA, Strasnick B, Newman A, Dodd LG. Midline nasal destruction in cocaine abusers. Otolaryngol Head Neck Surg 1991; 105: 694–701.
53. Trimarchi M, Gregorini G, Facchetti F, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine (Balt) 2001; 80: 391–404.
54. Westra WH, Holmes GF, Eisele DW. Bizarre epithelial atypia of the sinonasal tract after chemotherapy. Am J Surg Pathol 2001; 25: 652–656.
55. Natvig K, Larsen TE. Mucocele of the paranasal sinuses. A retrospective clinical and histological study. J Laryngol Otol 1978; 92: 1075–1082.
56. Chandra RK, Abrol BM. Immunopathology of nasal polypi. J Laryngol Otol 1974; 88: 1019–1024.
57. Drake-Lee AB, Lowe D, Swanston A, Grace A. Clinical profile and recurrence of nasal polyps. J Laryngol Otol 1984; 98: 783–793.
58. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol 1977; 59: 17–21.
59. Compagno J, Hyams VJ, Lepore ML. Nasal polyposis with stromal atypia. Review of follow-up study of 14 cases. Arch Pathol Lab Med 1976; 100: 224–226.
60. Klenoff BH, Goodman ML. Mesenchymal cell atypicality in inflammatory polyps. J Laryngol Otol 1977; 91: 751–756.
61. Nakayama M, Wenig BM, Heffner DK. Atypical stromal cells in inflammatory nasal polyps: immunohistochemical and ultrastructural analysis in defining histogenesis. Laryngoscope 1995; 105: 127–134.
62. Hardy G. The choanal polyp. Ann Otol Rhinol Laryngol 1957; 66: 306–326.
63. Sirola R. Choanal polyps. Acta Otolaryngol 1966; 61: 42–48.
64. Smith CJ, Echevarria R, McLelland CA. Pseudosarcomatous changes in antrochoanal polyps. Arch Otolaryngol 1974; 99: 228–230.
65. Berman JM, Colman BH. Nasal aspects of cystic fibrosis in children. J Laryngol Otol 1977; 91: 133–139.
66. Oppenheimer EH, Rosenstein BJ. Differential pathology of nasal polyps in cystic fibrosis and atopy. Lab Invest 1979; 40: 445–449.
67. Wenig BM, Heffner DK. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract and nasopharynx: a clinicopathologic study of 31 cases. Ann Otol Rhinol Laryngol 1995; 104: 639–645.
68. Ozolek JA, Hunt JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol 2006; 30: 1576–1580.
69. Weinreb I, Gnepp DR, Laver NM, et al. Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology 2009; 54: 205–213.
70. Jo VY, Mills SE, Cathro HP, Carlson DL, Stelow EB. Low-grade sinonasal adenocarcinomas: the association with and distinction from respiratory epithelial adenomatoid hamartomas and other glandular lesions. Am J Surg Pathol 2009; 33: 401–408.
71. Flavin R, Russell J, Phelan E, McDermott MB. Chondro-osseous respiratory epithelial adenomatoid hamartoma of the nasal cavity: a case report. Int J Pediatr Otorhinolaryngol 2005; 69: 87–91.
72. McDermott MB, Ponder TB, Dehner LP. Nasal chondromesenchymal hamartoma: an upper respiratory tract analogue of the chest wall mesenchymal hamartoma. Am J Surg Pathol 1998; 22: 425–433.
73. Norman ES, Bergman S, Trupiano JK. Nasal chondromesenchymal hamartoma: report of a case and review of the literature. Pediatr Dev Pathol 2004; 7: 517–520.
74. Ozolek JA, Carrau R, Barnes EL, Hunt JL. Nasal chondromesenchymal hamartoma in older children and adults: series and immunohistochemical analysis. Arch Pathol Lab Med 2005; 129: 1444–1450.
75. Priest JR, Williams GM, Mize WA, Dehner LP, McDermott MB. Nasal chondromesenchymal hamartoma in children with pleuropulmonary blastoma – a report from the International Pleuropulmonary Blastoma Registry. Int J Pediatr Otorhinolaryngol 2010; 74: 1240–1244.
76. Wenig BM. Schneiderian-type mucosal papillomas of the middle ear and mastoid. Ann Otol Rhinol Laryngol 1996; 105: 226–233.
77. Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971; 80: 192–206.
78. Ridolfi RL, Lieberman PH, Erlandson RA, Moore OS. Schneiderian papillomas: a clinicopathologic study of 30 cases. Am J Surg Pathol 1977; 1: 43–53.
79. Snyder RN, Perzin KH. Papillomatosis of nasal cavity and paranasal sinuses (inverted papilloma, squamous papilloma). A clinicopathologic study. Cancer 1972; 30: 668–690.
80. Christensen WN, Smith RR. Schneiderian papillomas: a clinicopathologic study of 67 cases. Hum Pathol 1986; 17: 393–400.
81. Gaffey MJ, Frierson HF, Weiss LM, et al. Human papillomavirus and Epstein–Barr virus in sinonasal Schneiderian papillomas. An in situ hybridization and polymerase chain reaction study. Am J Clin Pathol 1996; 106: 475–482.
82. Kelly JH, Joseph M, Carroll E, et al. Inverted papilloma of the nasal septum. Arch Otolaryngol 1980; 106: 767–771.
83. Manivel C, Wick MR, Dehner LP. Transitional (cylindric) cell carcinoma with endodermal sinus tumor-like features of the nasopharynx and paranasal sinuses. Clinicopathologic and immunohistochemical study of two cases. Arch Pathol Lab Med 1986; 110: 198–202.
84. Barnes L, Bedetti C. Oncocytic Schneiderian papilloma: a reappraisal of cylindrical cell papilloma of the sinonasal tract. Hum Pathol 1984; 15: 344–351.
85. Ward BE, Fechner RE, Mills SE. Carcinoma arising in oncocytic Schneiderian papilloma. Am J Surg Pathol 1990; 14: 364–369.
86. Kapadia SB, Barnes L, Pelzman K, et al. Carcinoma ex oncocytic Schneiderian (cylindrical cell) papilloma. Am J Otolaryngol 1993; 14: 332–338.
87. Barnes L, Eveson JW, Reichert PA, Sidransky D, eds. World Health Organization Classification. Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005.
88. Vaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996; 5: 587–593.
89. Polesel J, Franceschi S, Talamini R, et al. Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population. Oral Oncol 2011; 47: 541–545.
90. Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol 1995; 16: 103–108.
91. Neel HB, 3rd. Nasopharyngeal carcinoma. Clinical presentation, diagnosis, treatment, and prognosis. Otolaryngol Clin North Am 1985; 18: 479–490.
92. Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hematol 2000; 33: 91–98.
93. Jeyakumar A, Brickman TM, Jeyakumar A, Doerr T. Review of nasopharyngeal carcinoma. Ear Nose Throat J 2006, 85: 168–170, 172–163, 184.
94. Vasef MA, Ferlito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein–Barr virus. Ann Otol Rhinol Laryngol 1997; 106: 348–356.
95. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005; 365: 2041–2054.
96. Deyrup AT. Epstein–Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol 2008; 39: 473–483.
97. Nicholls JM, Agathanggelou A, Fung K, Zeng X, Niedobitek G. The association of squamous cell carcinomas of the nasopharynx with Epstein–Barr virus shows geographical variation reminiscent of Burkitt’s lymphoma. J Pathol 1997; 183: 164–168.
98. Zhang JX, Chen HL, Zong YS, et al. Epstein–Barr virus expression within keratinizing nasopharyngeal carcinoma. J Med Virol 1998; 55: 227–233.
99. Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000–2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol 2012; 22: 107–116.
100. Creely JJ Jr, Lyons GD Jr, Trail ML. Cancer of the nasopharynx: a review of 114 cases. South Med J 1973; 66: 405–409.
101. Rottey S, Madani I, Deron P, Van Belle S. Modern treatment for nasopharyngeal carcinoma: current status and prospects. Curr Opin Oncol 2011; 23: 254–258.
102. Carbone A, Micheau C. Pitfalls in microscopic diagnosis of undifferentiated carcinoma of nasopharyngeal type (lymphoepithelioma). Cancer 1982; 50: 1344–1351.
103. Ferlito A, Weiss LM, Rinaldo A, et al. Clinicopathological consultation. Lymphoepithelial carcinoma of the larynx hypopharynx, and trachea. Ann Otol Rhinol Laryngol 1997; 106: 437–444.
104. Pathmanathan R, Prasad U, Chandrika G, et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein–Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355–1367.
105. Stelow EB, Mills SE. Squamous cell carcinoma variants of the upper aerodigestive tract. Am J Clin Pathol 2005; 124(Suppl): S96–109.
106. Giffler RF, Gillespie JJ, Ayala AG, Newland JR. Lymphoepithelioma in cervical lymph nodes of children and young adults. Am J Surg Pathol 1977; 1: 293–302.
107. Madri JA, Barwick KW. An immunohistochemical study of nasopharyngeal neoplasms using keratin antibodies: epithelial versus nonepithelial neoplasms. Am J Surg Pathol 1982; 6: 143–149.
108. Shi SR, Goodman ML, Bhan AK, et al. Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies. Am J Pathol 1984; 117: 53–63.
109. Taxy JB, Hidvegi DF, Battifora H. Nasopharyngeal carcinoma: antikeratin immunohistochemistry and electron microscopy. Am J Clin Pathol 1985; 83: 320–325.
110. Ziegels-Weissman J, Nadji M, Penneys NS, Morales AR. Prekeratin immunohistochemistry in the diagnosis of undifferentiated carcinoma of the nasopharyngeal type. Arch Pathol Lab Med 1984; 108: 588–589.
111. Pinkus GS, Kurtin PJ. Epithelial membrane antigen – a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 1985; 16: 929–940.
112. Sloane JP, Ormerod MG. Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 1981; 47: 1786–1795.
113. Bourne TD, Bellizzi AM, Stelow EB, et al. p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol 2008; 130: 213–218.
114. Kurtin PJ, Pinkus GS. Leukocyte common antigen – a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Hum Pathol 1985; 16: 353–365.
115. Lauder I, Holland D, Mason DY, Gowland G, Cunliffe WJ. Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology 1984; 8: 259–272.
116. Warnke RA, Gatter KC, Falini B, et al. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med 1983; 309: 1275–1281.
117. Chao TY, Chow KC, Chang JY, et al. Expression of Epstein–Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma. Cancer 1996; 78: 24–29.
118. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein–Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol 1995; 103: 308–315.
119. Hsiao JR, Jin YT, Tsai ST. EBER1 in situ hybridization as an adjuvant for diagnosis of recurrent nasopharyngeal carcinoma. Anticancer Res 1998; 18: 4585–4589.
120. Hwang TZ, Jin YT, Tsai ST. EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx. Anticancer Res 1998; 18: 4581–4584.
121. Tsai ST, Jin YT, Mann RB, Ambinder RF. Epstein–Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer 1998; 82: 1449–1453.
122. Plaza G, Manzanal AI, Fogue L, et al. Association of Epstein–Barr virus and nasopharyngeal carcinoma in Caucasian patients. Ann Otol Rhinol Laryngol 2002; 111: 210–216.
123. Zarate-Osorno A, Jaffe ES, Medeiros LJ. Metastatic nasopharyngeal carcinoma initially presenting as cervical lymphadenopathy. A report of two cases that resembled Hodgkin’s disease. Arch Pathol Lab Med 1992; 116: 862–865.
124. Lewis JS, Castro EB. Cancer of the nasal cavity and paranasal sinuses. J Laryngol Otol 1972; 86: 255–262.
125. Kermer C, Poeschl PW, Wutzl A, et al. Surgical treatment of squamous cell carcinoma of the maxilla and nasal sinuses. J Oral Maxillofac Surg 2008; 66: 2449–2453.
126. Dahlstrom KR, Little JA, Zafereo ME, et al. Squamous cell carcinoma of the head and neck in never smoker–never drinkers: a descriptive epidemiologic study. Head Neck 2008; 30: 75–84.
127. Bonneterre V, Deschamps E, Persoons R, et al. Sino-nasal cancer and exposure to leather dust. Occup Med (Lond) 2007; 57: 438–443.
128. Feron VJ, Arts JH, Kuper CF, Slootweg PJ, Woutersen RA. Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol 2001; 31: 313–347.
129. Luce D, Leclerc A, Begin D, et al. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes & Control 2002; 13: 147–157.
130. Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 2009; 115: 2701–2709.
131. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013; 37: 185–192.
132. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2005; 29: 1367–1372.
133. Haraguchi H, Ebihara S, Saikawa M, et al. Malignant tumors of the nasal cavity: review of a 60-case series. Jpn J Clin Oncol 1995; 25: 188–194.
134. Daele JJ, Vander Poorten V, Rombaux P, Hamoir M. Cancer of the nasal vestibule, nasal cavity and paranasal sinuses. B-ENT 2005; Suppl 1: 87–94; quiz 95–86.
135. Waldron J, Witterick I. Paranasal sinus cancer: caveats and controversies. World J Surg 2003; 27: 849–855.
136. Waldron JN, O’Sullivan B, Gullane P, et al. Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 2000; 57: 167–173.
137. Agrawal R, Martin FW. Unusual presentation of verrucous carcinoma of maxillary antrum. J Otolaryngol 1992; 21: 371–372.
138. Durden FL Jr, Moore CE, Muller S. Verrucous carcinoma of the paranasal sinuses: a case report. Ear Nose Throat J 2010; 89: E21–23.
139. Hanna GS, Ali MH. Verrucous carcinoma of the nasal septum. J Laryngol Otol 1987; 101: 184–187.
140. Orvidas LJ, Lewis JE, Olsen KD, Weiner JS. Intranasal verrucous carcinoma: relationship to inverting papilloma and human papillomavirus. Laryngoscope 1999; 109: 371–375.
141. Pothula VB, Jones HS. Verrucous squamous carcinoma of the nasal septum. J Laryngol Otol 1998; 112: 172–173.
142. Alos L, Castillo M, Nadal A, et al. Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases. Histopathology 2004; 44: 570–579.
143. Gerughty RM, Hennigar GR, Brown FM. Adenosquamous carcinoma of the nasal, oral and laryngeal cavities. A clinicopathologic survey of ten cases. Cancer 1968; 22: 1140–1155.
144. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol 2011; 5: 108–116.
145. Shinhar SY, Heckathorn CL. Adenosquamous carcinoma of the nasal cavity. Ear Nose Throat J 2008; 87: 612–614.
146. Leventon GS, Evans HL. Sarcomatoid squamous cell carcinoma of the mucous membranes of the head and neck: a clinicopathologic study of 20 cases. Cancer 1981; 48: 994–1003.
147. Lu SY, Eng HL, Huang CC, et al. Basaloid squamous cell carcinoma of the sinonasal tract: report of two cases. Otolaryngol Head Neck Surg 2006; 134: 883–885.
148. Wieneke JA, Thompson LD, Wenig BM. Basaloid squamous cell carcinoma of the sinonasal tract. Cancer 1999; 85: 841–854.
149. Husain Q, Kanumuri VV, Svider PF, et al. Sinonasal adenoid cystic carcinoma: systematic review of survival and treatment strategies. Otolaryngol Head Neck Surg 2013; 148: 29–39.
150. Lupinetti AD, Roberts DB, Williams MD, et al. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer 2007; 110: 2726–2731.
151. Manning JT, Batsakis JG. Salivary-type neoplasms of the sinonasal tract. Ann Otol Rhinol Laryngol 1991; 100: 691–694.
152. Heffner DK. Sinonasal and laryngeal salivary gland lesions. In: Ellis GL, Auclair PL, Gnepp DR, eds. Surgical Pathology of the Salivary Glands. Philadelphia, PA: W.B. Saunders; 1991: pp. 544–559.
153. Narozny W, Kuczkowski J, Mikaszewski B. Pleomorphic adenoma of the nasal cavity: clinical analysis of 8 cases. Am J Otolaryngol 2005; 26: 218.
154. Neto AG, Pineda-Daboin K, Spencer ML, Luna MA. Sinonasal acinic cell carcinoma: a clinicopathologic study of four cases. Head Neck 2005; 27: 603–607.
155. Seethala RR, Barnes EL, Hunt JL. Epithelial–myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol 2007; 31: 44–57.
156. Begin LR, Rochon L, Frenkiel S. Spindle cell myoepithelioma of the nasal cavity. Am J Surg Pathol 1991; 15: 184–190.
157. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6–NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010; 34: 599–608.
158. Cho KJ, el-Naggar AK, Mahanupab P, Luna MA, Batsakis JG. Carcinoma ex-pleomorphic adenoma of the nasal cavity: a report of two cases. J Laryngol Otol 1995; 109: 677–679.
159. Cimino-Mathews A, Lin BM, Chang SS, Boahene KD, Bishop JA. Carcinoma ex pleomorphic adenoma of the nasal cavity. Head Neck Pathol 2011; 5: 405–409.
160. Higo R, Takahashi T, Nakata H, Harada H, Sugasawa M. Salivary duct carcinoma in the sinonasal tract. Eur Arch Otorhinolaryngol 2007; 264: 561–563.
161. Dehner LP, Valbuena L, Perez-Atayde A, et al. Salivary gland anlage tumor (“congenital pleomorphic adenoma”). A clinicopathologic, immunohistochemical and ultrastructural study of nine cases. Am J Surg Pathol 1994; 18: 25–36.
162. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 10: 192–202.
163. Ironside P, Matthews J. Adenocarcinoma of the nose and paranasal sinuses in woodworkers in the state of Victoria, Australia. Cancer 1975; 36: 1115–1124.
164. Hadfield EH, Macbeth RG. Adenocarcinoma of ethmoids in furniture workers. Ann Otol Rhinol Laryngol 1971; 80: 699–703.
165. Klintenberg C, Olofsson J, Hellquist H, Sokjer H. Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer 1984; 54: 482–488.
166. Imbus HR, Dyson WL. A review of nasal cancer in furniture manufacturing and woodworking in North Carolina, the United States, and other countries. J Occup Med 1987; 29: 734–740.
167. Acheson ED, Cowdell RH, Hadfield E, Macbeth RG. Nasal cancer in woodworkers in the furniture industry. Br Med J 1968; 2: 587–596.
168. Hadfield EH. A study of adenocarcinoma of the paranasal sinuses in woodworkers in the furniture industry. Ann R Coll Surg Engl 1970; 46: 301–319.
169. Sanchez-Casis G, Devine KD, Weiland LH. Nasal adenocarcinomas that closely simulate colonic carcinomas. Cancer 1971; 28: 714–720.
170. Kleinsasser O, Schroeder HG. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otorhinolaryngol 1988; 245: 1–15.
171. Mills SE, Fechner RE, Cantrell RW. Aggressive sinonasal lesion resembling normal intestinal mucosa. Am J Surg Pathol 1982; 6: 803–809.
172. Choi HR, Sturgis EM, Rashid A, et al. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol 2003; 34: 1101–1107.
173. Franchi A, Massi D, Palomba A, Biancalani M, Santucci M. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Arch 2004; 445: 63–67.
174. Cathro HP, Mills SE. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Am J Surg Pathol 2004; 28: 1026–1032.
175. Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004; 57: 932–937.
176. McKinney CD, Mills SE, Franquemont DW. Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol 1995; 8: 421–426.
177. Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer 1982; 50: 312–322.
178. Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma. A clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol 1988; 12: 946–953.
179. Stelow EB, Mills SE, Jo VY, Carlson DL. Adenocarcinoma of the upper aerodigestive tract. Adv Anat Pathol 2010; 17: 262–269.
180. Stelow EB, Jo VY, Mills SE, Carlson DL. A histologic and immunohistochemical study of high-grade non-intestinal sinonasal adenocarcinomas. Am J Surg Pathol 2011; 35: 971–980.
181. Orvidas LJ, Lewis JE, Weaver AL, Bagniewski SM, Olsen KD. Adenocarcinoma of the nose and paranasal sinuses: a retrospective study of diagnosis, histologic characteristics, and outcomes in 24 patients. Head Neck 2005; 27: 370–375.
182. Zur KB, Brandwein M, Wang B, et al. Primary description of a new entity, renal cell-like carcinoma of the nasal cavity: van Meegeren in the house of Vermeer. Arch Otolaryngol Head Neck Surg 2002; 128: 441–447.
183. Maitra A, Baskin LB, Lee EL. Malignancies arising in oncocytic schneiderian papillomas: a report of 2 cases and review of the literature. Arch Pathol Lab Med 2001; 125: 1365–1367.
184. Pineda-Daboin K, Neto A, Ochoa-Perez V, Luna MA. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes. Ann Diagn Pathol 2006; 10: 215–221.
185. Zeizafoun N, Elmberger G, Wenig BM. Thyroid transcription factor (TTF-1) immunoreactivity in low-grade nasopharyngeal papillary adenocarcinomas (LGNPPA): a report of three cases. Mod Pathol 2007; 20: 231–232A.
186. Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 1986; 10: 771–779.
187. Jeng YM, Sung MT, Fang CL, et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol 2002; 26: 371–376.
188. Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol 2005; 12: 134–143.
189. Enepekides DJ. Sinonasal undifferentiated carcinoma: an update. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 222–225.
190. Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002; 112: 1450–1455.
191. Iezzoni JC, Mills SE. “Undifferentiated” small round cell tumors of the sinonasal tract: differential diagnosis update. Am J Clin Pathol 2005; 124(Suppl): S110–121.
192. Cerilli LA, Holst VA, Brandwein MS, Stoler MH, Mills SE. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 2001; 25: 156–163.
193. Perez-Ordonez B, Caruana SM, Huvos AG, Shah JP. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol 1998; 29: 826–832.
194. Babin E, Rouleau V, Vedrine PO, et al. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol 2006; 120: 289–297.
195. Franchi A, Sardi I, Cetica V, et al. Pediatric sinonasal neuroendocrine carcinoma after treatment of retinoblastoma. Hum Pathol 2009; 40: 750–755.
196. Frierson HF Jr, Ross GW, Stewart FM, Newman SA, Kelly MD. Unusual sinonasal small-cell neoplasms following radiotherapy for bilateral retinoblastomas. Am J Surg Pathol 1989; 13: 947–954.
197. Jain R, Gramigna V, Sanchez-Marull R, Perez-Ordonez B. Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract. J Clin Pathol 2009; 62: 634–637.
198. Schafer DR, Thompson LD, Smith BC, Wenig BM. Primary ameloblastoma of the sinonasal tract: a clinicopathologic study of 24 cases. Cancer 1998; 82: 667–674.
199. Kumamoto H, Ohki K, Ooya K. Expression of p63 and p73 in ameloblastomas. J Oral Pathol Med 2005; 34: 220–226.
200. French CA. Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol 2010; 63: 492–496.
201. French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004; 22: 4135–4139.
202. Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol 2008; 32: 828–834.
203. Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 2012; 18: 5773–5779.
204. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009; 33: 984–991.
205. Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol 2011; 5: 31–35.
206. Stelow EB, French CA. Carcinomas of the upper aerodigestive tract with rearrangement of the nuclear protein of the testis (NUT) gene (NUT midline carcinomas). Adv Anat Pathol 2009; 16: 92–96.
207. Vargas SO, French CA, Faul PN, et al. Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course. Cancer 2001; 92: 1195–1203.
208. Franquemont DW, Mills SE. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol 1991; 96: 689–697.
209. Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003; 27: 594–611.
210. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1664–1678.
211. Cohen Y, Rosenbaum E, Begum S, et al. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 2004; 10: 3444–3447.
212. van Dijk M, Sprenger S, Rombout P, et al. Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization. Genes Chromosomes Cancer 2003; 36: 151–158.
213. Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA. Sinonasal tract melanoma or clear cell sarcoma? Molecular evaluation of 4 cases diagnosed as malignant melanoma. Mod Pathol 2008; 21: 238A–238A.
214. Wick MR, Stanley SJ, Swanson PE. Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti-synaptophysin. Arch Pathol Lab Med 1988; 112: 616–620.
215. Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol 2001; 25: 782–787.
216. Snyder ML, Paulino AF. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas. Head Neck 2002; 24: 52–55.
217. Feeley C, Theaker J. Epithelial markers in primary sinonasal mucosal melanoma. Histopathology 2004; 45: 96–98.
218. Jones JE, McGill T. Peripheral primitive neuroectodermal tumors of the head and neck. Arch Otolaryngol Head Neck Surg 1995; 121: 1392–1395.
219. Jurgens H, Bier V, Harms D, et al. Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 1988; 61: 349–357.
220. Nikitakis NG, Salama AR, O’Malley BW Jr, Ord RA, Papadimitriou JC. Malignant peripheral primitive neuroectodermal tumor–peripheral neuroepithelioma of the head and neck: a clinicopathologic study of five cases and review of the literature. Head Neck 2003; 25: 488–498.
221. Windfuhr JP. Primitive neuroectodermal tumor of the head and neck: incidence, diagnosis, and management. Ann Otol Rhinol Laryngol 2004; 113: 533–543.
222. Hafezi S, Seethala RR, Stelow EB, et al. Ewing’s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol 2011; 5: 8–16.
223. Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing’s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 1988; 32: 229–238.
224. Folpe AL, Goldblum JR, Rubin BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 2005; 29: 1025–1033.
225. Folpe AL, Hill CE, Parham DM, O’Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing’s sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000; 24: 1657–1662.
226. Mills SE, Frierson HF Jr. Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol 1985; 9: 317–327.
227. Frierson HF Jr, Ross GW, Mills SE, Frankfurter A. Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol 1990; 94: 547–553.
228. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 1571–1576.
229. Guled M, Myllykangas S, Frierson HF Jr, et al. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol 2008; 21: 770–778.
230. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg 2006; 132: 134–138.
231. Diaz EM Jr, Johnigan RH 3rd, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005; 27: 138–149.
232. Mills SE, Gaffey MJ, Frierson HF. Neural, neuroendocrine, and neuroectodermal neoplasia. In: Tumors of The Upper Aerodigestive Tract and Ear. Washington, DC: AFIP; 2000: p. 159.
233. Hirose T, Scheithauer BW, Lopes MB, et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 1995; 76: 4–19.
234. Lack EE, Cubilla AL, Woodruff JM, Farr HW. Paragangliomas of the head and neck region: a clinical study of 69 patients. Cancer 1977; 39: 397–409.
235. Lack EE, Cubilla AL, Woodruff JM. Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients. Hum Pathol 1979; 10: 191–218.
236. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346: 1459–1466.
237. Kliewer KE, Wen DR, Cancilla PA, Cochran AJ. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol 1989; 20: 29–39.
238. Johnson TL, Zarbo RJ, Lloyd RV, Crissman JD. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing. Mod Pathol 1988; 1: 216–223.
239. Gorlin RJ, Sedano HO, Vickers RA, Cervenka J. Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid – a syndrome. Cancer 1968; 22: 293–299, passim.
240. Perzin KH, Panyu H, Wechter S. Nonepithelial tumors of the nasal cavity, paranasal sinuses and nasopharynx. A clinicopathologic study. XII: Schwann cell tumors (neurilemoma, neurofibroma, malignant schwannoma). Cancer 1982; 50: 2193–2202.
241. Cangiarella J, Jagirdar J, Adelman H, Budzilovich G, Greco MA. Mucosal neuromas and plexiform neurofibromas: an immunocytochemical study. Pediatr Pathol 1993, 13: 281–288.
242. Hasegawa SL, Mentzel T, Fletcher CD. Schwannomas of the sinonasal tract and nasopharynx. Mod Pathol 1997; 10: 777–784.
243. Buob D, Wacrenier A, Chevalier D, et al. Schwannoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of 5 cases. Arch Pathol Lab Med 2003; 127: 1196–1199.
244. Hillstrom RP, Zarbo RJ, Jacobs JR. Nerve sheath tumors of the paranasal sinuses: electron microscopy and histopathologic diagnosis. Otolaryngol Head Neck Surg 1990; 102: 257–263.
245. Hellquist HB, Lundgren J. Neurogenic sarcoma of the sinonasal tract. J Laryngol Otol 1991; 105: 186–190.
246. Heffner DK, Gnepp DR. Sinonasal fibrosarcomas, malignant schwannomas, and “Triton” tumors. A clinicopathologic study of 67 cases. Cancer 1992; 70: 1089–1101.
247. Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol 2011; 135: 839–844.
248. Lewis JT, Oliveira AM, Nascimento AG, et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol 2012; 36: 517–525.
249. Thompson LD, Gyure KA. Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol 2000; 24: 640–650.
250. Luk IS, Chan JK, Chow SM, Leung S. Pituitary adenoma presenting as sinonasal tumor: pitfalls in diagnosis. Hum Pathol 1996; 27: 605–609.
251. Langford L, Batsakis JG. Pituitary gland involvement of the sinonasal tract. Ann Otol Rhinol Laryngol 1995; 104: 167–169.
252. Thompson LD, Seethala RR, Muller S. Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the English literature. Head Neck Pathol 2012; 6: 75–100.
253. Byrne MN, Sessions DG. Nasopharyngeal craniopharyngioma. Case report and literature review. Ann Otol Rhinol Laryngol 1990; 99: 633–639.
254. Fu YS, Perzin KH. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. VI. Fibrous tissue tumors (fibroma, fibromatosis, fibrosarcoma). Cancer 1976; 37: 2912–2928.
255. Allen PW. The fibromatoses: a clinicopathologic classification based on 140 cases. Am J Surg Pathol 1977; 1: 255–270.
256. Gnepp DR, Henley J, Weiss S, Heffner D. Desmoid fibromatosis of the sinonasal tract and nasopharynx. A clinicopathologic study of 25 cases. Cancer 1996; 78: 2572–2579.
257. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005; 29: 653–659.
258. Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol 2003; 27: 737–749.
259. Witkin GB, Rosai J. Solitary fibrous tumor of the upper respiratory tract. A report of six cases. Am J Surg Pathol 1991; 15: 842–848.
260. Zukerberg LR, Rosenberg AE, Randolph G, Pilch BZ, Goodman ML. Solitary fibrous tumor of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1991; 15: 126–130.
261. Cox DP, Daniels T, Jordan RC. Solitary fibrous tumor of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: 79–84.
262. Guillou L, Fletcher JA, Fletcher CDM, Mandahl N. Extrapleural solitary fibrous tumour and haemangiopericytoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Tumours of the Soft Tissue and Bone. Lyon: IARC Press; 2002: pp. 86–90.
263. Yang XJ, Zheng JW, Ye WM, et al. Malignant solitary fibrous tumors of the head and neck: a clinicopathological study of nine consecutive patients. Oral Oncol 2009; 45: 678–682.
264. Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component – is this dedifferentiated SFT? Am J Surg Pathol 2009; 33: 1314–1321.
265. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995; 19: 859–872.
266. Chen YF, Zhang WD, Wu MW, Ou-Yang D, Zhang Q. Inflammatory myofibroblastic tumor of the head and neck. Med Oncol 2011; 28(Suppl 1): S349–S353.
267. Ong HS, Ji T, Zhang CP, et al. Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features. Oral Oncol 2012; 48: 141–148.
268. Bentz BG, Singh B, Woodruff J, et al. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol 2004; 11: 619–628.
269. Frankenthaler R, Ayala AG, Hartwick RW, Goepfert H. Fibrosarcoma of the head and neck. Laryngoscope 1990; 100: 799–802.
270. Pritchard DJ, Soule EH, Taylor WF, Ivins JC. Fibrosarcoma – a clinicopathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk. Cancer 1974; 33: 888–897.
271. Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Tumors of the Soft Tissues. Washington, DC, Armed Forces Institute of Pathology; 2001: p. 507.
272. McKiernan DC, Watters GW. Smooth muscle tumours of the larynx. J Laryngol Otol 1995; 109: 77–79.
273. Huang HY, Antonescu CR. Sinonasal smooth muscle cell tumors: a clinicopathologic and immunohistochemical analysis of 12 cases with emphasis on the low-grade end of the spectrum. Arch Pathol Lab Med 2003; 127: 297–304.
274. Kuruvilla A, Wenig BM, Humphrey DM, Heffner DK. Leiomyosarcoma of the sinonasal tract. A clinicopathologic study of nine cases. Arch Otolaryngol Head Neck Surg 1990; 116: 1278–1286.
275. Kapadia SB, Meis JM, Frisman DM, Ellis GL, Heffner DK. Fetal rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study of 24 cases. Hum Pathol 1993; 24: 754–765.
276. Kapadia SB, Meis JM, Frisman DM, et al. Adult rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study. Hum Pathol 1993; 24: 608–617.
277. Kodet R, Fajstavr J, Kabelka Z, et al. Is fetal cellular rhabdomyoma an entity or a differentiated rhabdomyosarcoma? A study of patients with rhabdomyoma of the tongue and sarcoma of the tongue enrolled in the intergroup rhabdomyosarcoma studies I, II, and III. Cancer 1991; 67: 2907–2913.
278. Willis J, Abdul-Karim FW, di Sant’Agnese PA. Extracardiac rhabdomyomas. Semin Diagn Pathol 1994; 11: 15–25.
279. Hicks J, Flaitz C. Rhabdomyosarcoma of the head and neck in children. Oral Oncol 2002; 38: 450–459.
280. Newton WA Jr, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification – an Intergroup Rhabdomyosarcoma Study. Cancer 1995; 76: 1073–1085.
281. Pappo A, Barr FG, Wolden SL. Pediatric rhabdomyosarcoma: biology and results of the North American Intergroup Rhabdomyosarcoma Trials. In: Pappo A, ed. Pediatric Bone and Soft Tissue Sarcomas. Berlin: Springer; 2006: pp. 103–132.
282. Pappo AS, Meza JL, Donaldson SS, et al. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol 2003; 21: 638–645.
283. Qualman SJ, Coffin CM, Newton WA, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998; 1: 550–561.
284. Tsokos M. The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994; 11: 26–38.
285. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001; 25: 1150–1157.
286. Devoe K, Weidner N. Immunohistochemistry of small round-cell tumors. Semin Diagn Pathol 2000; 17: 216–224.
287. Coffin CM, Dehner LP. Vascular tumors in children and adolescents: a clinicopathologic study of 228 tumors in 222 patients. Pathol Annu 1993; 28(Pt 1): 97–120.
288. Fu YS, Perzin KH. Non-epithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: a clinicopathologic study. I. General features and vascular tumors. Cancer 1974; 33: 1275–1288.
289. Mills SE, Cooper PH, Fechner RE. Lobular capillary hemangioma: the underlying lesion of pyogenic granuloma. A study of 73 cases from the oral and nasal mucous membranes. Am J Surg Pathol 1980; 4: 470–479.
290. Apostol JV, Frazell EL. Juvenile nasopharyngeal angiofibroma. A clinical study. Cancer 1965; 18: 869–878.
291. Hubbard EM. Nasopharyngeal angiofibromas. AMA Arch Pathol 1958; 65: 192–204.
292. Neel HB 3rd, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma. Review of 120 cases. Am J Surg 1973; 126: 547–556.
293. Sternberg SS. Pathology of juvenile nasopharyngeal angiofibroma; a lesion of adolescent males. Cancer 1954; 7: 15–28.
294. Giardiello FM, Hamilton SR, Krush AJ, et al. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology 1993; 105: 1550–1552.
295. Guertl B, Beham A, Zechner R, Stammberger H, Hoefler G. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol 2000; 31: 1411–1413.
296. Chen KT, Bauer FW. Sarcomatous transformation of nasopharyngeal angiofibroma. Cancer 1982; 49: 369–371.
297. Spagnolo DV, Papadimitriou JM, Archer M. Postirradiation malignant fibrous histiocytoma arising in juvenile nasopharyngeal angiofibroma and producing alpha-1-antitrypsin. Histopathology 1984; 8: 339–352.
298. Beham A, Fletcher CD, Kainz J, Schmid C, Humer U. Nasopharyngeal angiofibroma: an immunohistochemical study of 32 cases. Virchows Arch A Pathol Anat Histopathol 1993; 423: 281–285.
299. Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 1998; 11: 1122–1126.
300. Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 2001; 158: 1073–1078.
301. Eichhorn JH, Dickersin GR, Bhan AK, Goodman ML. Sinonasal hemangiopericytoma. A reassessment with electron microscopy, immunohistochemistry, and long-term follow-up. Am J Surg Pathol 1990; 14: 856–866.
302. Tse LL, Chan JK. Sinonasal haemangiopericytoma-like tumour: a sinonasal glomus tumour or a haemangiopericytoma? Histopathology 2002; 40: 510–517.
303. Thompson LDR, Fanburg-Smith JC, Wenig BM. Borderline and low malignant potential tumours of soft tissues. In Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumours. World Health Organization Classification of Tumours. Lyon: IARC Press; 2005: pp. 43–45.
304. Compagno J, Hyams VJ. Hemangiopericytoma-like intranasal tumors. A clinicopathologic study of 23 cases. Am J Clin Pathol 1976; 66: 672–683.
305. el-Naggar AK, Batsakis JG, Garcia GM, Luna ML, Goepfert H. Sinonasal hemangiopericytomas. A clinicopathologic and DNA content study. Arch Otolaryngol Head Neck Surg 1992; 118: 134–137.
306. Hooda S, Humphreys MR, Wong SW, Evans AS. Masson’s pseudotumour of the ethmoid sinus – a case report. J Laryngol Otol 2008; 122: 990–992.
307. Palacios E, Daroca PJ Jr. Nasal cavernous hemangioma. Ear Nose Throat J 2007; 86: 326, 328.
308. Di Girolamo A, Giacomini PG, Coli A, et al. Epithelioid haemangioendothelioma arising in the nasal cavity. J Laryngol Otol 2003; 117: 75–77.
309. Kurien M, Nair S, Thomas S. Angiosarcoma of the nasal cavity and maxillary antrum. J Laryngol Otol 1989; 103: 874–876.
310. Nelson BL, Thompson LD. Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature. Head Neck Pathol 2007; 1: 1–12.
311. Celenk F, Yilmaz M, Asal K, Ekinci O, Tokgoz N. AIDS-related primary Kaposi sarcoma of the nasopharynx. Ear Nose Throat J 2011; 90: E1–4.
312. Fliss DM, Parikh J, Freeman JL. AIDS-related Kaposi’s sarcoma of the sphenoid sinus. J Otolaryngol 1992; 21: 235–237.
313. Wyatt ME, Finlayson CJ, Moore-Gillon V. Kaposi’s sarcoma masquerading as pyogenic granuloma of the nasal mucosa. J Laryngol Otol 1998; 112: 280–282.
314. Heffner DK. Sinonasal angiosarcoma? Not likely (a brief description of infarcted nasal polyps). Ann Diagn Pathol 2010; 14: 233–234.
315. Hadravsky L, Skalova A, Kacerovska D, et al. Angiomatoid change in polyps of the nasal and paranasal regions: an underrecognized and commonly misdiagnosed lesion – report of 45 cases. Virchows Arch 2012; 460: 203–209.
316. Fu YS, Perzin KH. Non-epithelial tumors of the nasal cavity, paranasal sinuses and nasopharynx: a clinicopathologic study. VIII. Adipose tissue tumors (lipoma and liposarcoma). Cancer 1977; 40: 1314–1317.
317. Subramaniam MM, Shuen CS, Petersson F. Poorly differentiated synovial sarcoma of the sphenoid sinus: report of the first case and review of synovial sarcomas of the sinonasal tract. Histopathology 2012; 61: 1232–1237.
318. Finke NM, Lae ME, Lloyd RV, Gehani SK, Nascimento AG. Sinonasal desmoplastic small round cell tumor: a case report. Am J Surg Pathol 2002; 26: 799–803.
319. Singh G, Sharma MC, Suri V, et al. Alveolar soft part sarcoma of the paranasal sinuses masquerading as a giant invasive pituitary adenoma. Ann Diagn Pathol 2013; 17: 276–280.
320. Dahlin DC, Maccarty CS. Chordoma. Cancer 1952; 5: 1170–1178.
321. Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer 1973; 32: 410–420.
322. Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol 2006; 30: 811–818.
323. Mitchell A, Scheithauer BW, Unni KK, et al. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer 1993; 72: 2943–2949.
324. O’Connell JX, Renard LG, Liebsch NJ, et al. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer 1994; 74: 2261–2267.
325. Perzin KH, Pushparaj N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. XIV: Chordomas. Cancer 1986; 57: 784–796.
326. Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA. “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol 1987; 11: 516–525.
327. Mendenhall WM, Mendenhall CM, Lewis SB, Villaret DB, Mendenhall NP. Skull base chordoma. Head Neck 2005; 27: 159–165.
328. Wojno KJ, Hruban RH, Garin-Chesa P, Huvos AG. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Am J Surg Pathol 1992; 16: 1144–1152.
329. Sangoi AR, Karamchandani J, Lane B, et al. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod Pathol 2011; 24: 425–429.
330. Keel SB, Bhan AK, Liebsch NJ, Rosenberg AE. Chondromyxoid fibroma of the skull base: a tumor which may be confused with chordoma and chondrosarcoma. A report of three cases and review of the literature. Am J Surg Pathol 1997; 21: 577–582.
331. Veras EF, Santamaria IB, Luna MA. Sinonasal chondromyxoid fibroma. Ann Diagn Pathol 2009; 13: 41–46.
332. Knott PD, Gannon FH, Thompson LD. Mesenchymal chondrosarcoma of the sinonasal tract: a clinicopathological study of 13 cases with a review of the literature. Laryngoscope 2003; 113: 783–790.
333. Bertoni F, Picci P, Bacchini P, et al. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer 1983; 52: 533–541.
334. Dahlin DC, Henderson ED. Mesenchymal chondrosarcoma. Further observations on a new entity. Cancer 1962; 15: 410–417.
335. Waldron CA, Shafer WG. The central giant cell reparative granuloma of the jaws. An analysis of 38 cases. Am J Clin Pathol 1966; 45: 437–447.
336. Yamaguchi T, Dorfman HD. Giant cell reparative granuloma: a comparative clinicopathologic study of lesions in gnathic and extragnathic sites. Int J Surg Pathol 2001; 9: 189–200.
337. Chan J, Gannon FH, Thompson LD. Malignant giant cell tumor of the sphenoid. Ann Diagn Pathol 2003; 7: 100–105.
338. Fu YS, Perzin KH. Non-epithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. II. Osseous and fibro-osseous lesions, including osteoma, fibrous dysplasia, ossifying fibroma, osteoblastoma, giant cell tumor, and osteosarcoma. Cancer 1974; 33: 1289–1305.
339. Wenig BM, Vinh TN, Smirniotopoulos JG, et al. Aggressive psammomatoid ossifying fibromas of the sinonasal region: a clinicopathologic study of a distinct group of fibro-osseous lesions. Cancer 1995; 76: 1155–1165.
340. Eversole LR, Leider AS, Nelson K. Ossifying fibroma: a clinicopathologic study of sixty-four cases. Oral Surg Oral Med Oral Pathol 1985; 60: 505–511.
341. Demicco EG, Deshpande V, Nielsen GP, Kattapuram SV, Rosenberg AE. Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases. Am J Surg Pathol 2010; 34: 1647–1655.
342. Padilla RJ, Murrah VA. The spectrum of gnathic osteosarcoma: caveats for the clinician and the pathologist. Head Neck Pathol 2011; 5: 92–99.
343. Nora FE, Unni KK, Pritchard DJ, Dahlin DC. Osteosarcoma of extragnathic craniofacial bones. Mayo Clin Proc 1983; 58: 268–272.
344. Garrington GE, Scofield HH, Cornyn J, Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer 1967; 20: 377–391.
345. Clark JL, Unni KK, Dahlin DC, Devine KD. Osteosarcoma of the jaw. Cancer 1983; 51: 2311–2316.
346. van der Valk P, Meijer CJLM. Lymph nodes. In: Mills SE, ed. Histology for Pathologists. Philadelphia, PA: Lippincott Williams and Wilkins; 2007: pp. 763–781.
347. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 1972; 30: 1174–1188.
348. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969; 87: 63–70.
349. Foucar E, Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. Arch Otolaryngol 1978; 104: 687–693.
350. Wenig BM, Abbondanzo SL, Childers EL, Kapadia SB, Heffner DR. Extranodal sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease) of the head and neck. Hum Pathol 1993; 24: 483–492.
351. Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996; 20: 103–111.
352. Jaffe ES, Krenacs L, Kumar S, Kingma DW, Raffeld M. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol 1999; 111: S46–55.
353. Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol 2005; 12: 27–34.
354. Strickler JG, Meneses MF, Habermann TM, et al. Polymorphic reticulosis: a reappraisal. Hum Pathol 1994; 25: 659–665.
355. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein–Barr virus. Blood 1993; 81: 2688–2695.
356. Iqbal J, Kucuk C, Deleeuw RJ, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 2009; 23: 1139–1151.
357. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein–Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996; 77: 2137–2149.
358. Emile JF, Boulland ML, Haioun C, et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466–1473.
359. Schwartz EJ, Molina-Kirsch H, Zhao S, et al. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol 2008; 130: 343–351.
360. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780–2795.
361. Harris NL, Jaffe ES, Stein H, et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.
362. McKenna RW, Kyle RA, Kuehl WM, et al. Plasma cell neoplasms. In: Swerdlow JB, Campo E, Harris NL,et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008: pp. 200–213.
363. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999; 85: 2305–2314.
364. Batsakis JG, Fries GT, Goldman RT, Karlsberg RC. Upper respiratory tract plasmacytoma. Arch Otolaryngol 1964; 79: 613–618.
365. Batsakis JG, Medeiros JL, Luna MA, El-Naggar AK. Plasma cell dyscrasias and the head and neck. Ann Diagn Pathol 2002; 6: 129–140.
366. Fu YS, Perzin KH. Nonepithelial tumors of the nasal cavity, paranasal sinuses and nasopharynx. A clinicopathologic study. IX. Plasmacytomas. Cancer 1978; 42: 2399–2406.
367. Stout AP, Kenney FR. Primary plasma-cell tumors of the upper air passages and oral cavity. Cancer 1949; 2: 261–278.
368. Strickler JG, Audeh MW, Copenhaver CM, Warnke RA. Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma. Cancer 1988; 61: 1782–1786.
369. Grogan TM, Van Camp B, Kyle RA, Muller-Hermelink HK, Harris NL. Plasma cell neoplasms. In: Jaffe ES, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001: pp. 142–156.
370. Dehner LP. Gonadal and extragonadal germ cell neoplasia of childhood. Hum Pathol 1983; 14: 493–511.
371. Heffner DK. Problems in pediatric otorhinolaryngic pathology, III. Teratoid and neural tumors of the nose, sinonasal tract, and nasopharynx. Int J Pediatr Otorhinolaryngol 1983; 6: 1–21.
372. Lack EE. Extragonadal germ cell tumors of the head and neck region: review of 16 cases. Hum Pathol 1985; 16: 56–64.
373. Stephenson JA, Mayland DM, Kun LE, et al. Malignant germ cell tumors of the head and neck in childhood. Laryngoscope 1989; 99: 732–735.
374. Coppit GL 3rd, Perkins JA, Manning SC. Nasopharyngeal teratomas and dermoids: a review of the literature and case series. Int J Pediatr Otorhinolaryngol 2000; 52: 219–227.
375. Heffner DK, Hyams VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses. A clinicopathologic study of 20 cases. Cancer 1984; 53: 2140–2154.
376. Carrizo F, Pineda-Daboin K, Neto AG, Luna MA. Pharyngeal teratocarcinosarcoma: review of the literature and report of two cases. Ann Diagn Pathol 2006; 10: 339–342.
377. Naresh KN, Pai SA. Foci resembling olfactory neuroblastoma and craniopharyngioma are seen in sinonasal teratocarcinosarcomas. Histopathology 1998; 32: 84.
378. Harrison MS, Doey WD, Osborn DA. Intra-nasal metastasis from renal carcinoma. J Laryngol Otol 1964; 78: 103–107.
379. Johnson IJ, Campbell JB. Renal derived epistaxis. J Laryngol Otol 1993; 107: 144–145.
380. Nason R, Carrau RL. Metastatic renal cell carcinoma to the nasal cavity. Am J Otolaryngol 2004; 25: 54–57.
381. Yee LL, Keng CG. A rare case of renal cell carcinoma metastatic to the sinonasal area. Ear Nose Throat J 2001; 80: 462–467.
382. Hiromura Y, Dejima K, Imamura Y, Wada Y. Breast carcinoma metastatic to the sphenoid sinus: a case report. Otolaryngol Head Neck Surg 2003; 129: 756–758.
383. Lavasani L, Zapanta PE, Tanna N, Sadeghi N. Metastasis of prostatic adenocarcinoma to the sphenoid sinus. Ann Otol Rhinol Laryngol 2006; 115: 690–693.
384. Saleh HA, O’Flynn P, Jones NS. Prostatic metastases in the nose and paranasal sinuses. J Laryngol Otol 1993; 107: 629–632.
385. Kurisu Y, Tsuji M, Takeshita A, Hirata K, Shibayama Y. Cytologic findings of metastatic hepatocellular carcinoma of the nasal cavity: a report of 2 cases. Acta Cytol 2010; 54: 989–992.
386. Rombaux P, Hamoir M, Liistro G, Bertrand B. Frontal sinus tumor as the first sign of adenocarcinoma of the lung. Otolaryngol Head Neck Surg 2005; 132: 816–817.
387. Altman KW, Mirza N, Philippe L. Metastatic follicular thyroid carcinoma to the paranasal sinuses: a case report and review. J Laryngol Otol 1997; 111: 647–651.
388. Cama E, Agostino S, Ricci R, Scarano E. A rare case of metastases to the maxillary sinus from sigmoid colon adenocarcinoma. ORL J Otorhinolaryngol Relat Spec 2002; 64: 364–367.